Obermatt
See Similar Stocks →

Prenetics Global

NMQ:PRE · KYG722451229
Health Care Providers & ServicesSmall

360

52
Profit price72
Owner Earnings Yield1
Dividend Yield1
Price/Sales48
EV / Gross Profit60
Price/Book39
Return on Capital8
Cash Return on Capital8
Return on Equity12
EBIT Margin4
Gross Profitability63
Accruals85
Owner Earnings Margin6
Sales growth96
Profit growth11
Reinvestment4
Price momentum88
Debt load95
Refinancing30
Debt Payback1
Liquidity6
Analyst ratings100
Opinion Changes50
Price Target Upside76
Market mood65
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Prenetics Global doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Employees144
Websiteir.prenetics.com
ISINKYG722451229
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Digital WellnessFitness TechnologyLifestyleNutraceuticalArtificial IntelligenceGeneticsOncologyHealth DiagnosticsBiotechnologyHealth CarePersonal HealthWellness

Description

Prenetics Global Limited operates as a consumer health company. The company is advancing human health and longevity through science-backed products, global brand partnerships, and AI-driven operations. IM8: Flagship Consumer Health Brand IM8 was d…

Analysis

Weak and unloved

Prenetics Global Limited is weak and unloved: below-average business metrics and a price that reflects that disappointment.

Valuation data is not available for this company.

The trajectory is solid and the balance sheet is adequate. The company scores 6/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
67
2026

All-time high

67

Jun 2026

All-time low

52

Mar 2026

Average rank

60

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
48
—
—
—
Price/Earnings
95
—
—
—
Price/Book
39
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
61
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Prenetics Global with its peers
MicroAlgo
NAQ:MLGO
34
CountryChina
IndustryIT Services
SizeSmall
Full Stock Analysis →
MAAS
ASX:MGH
25
CountryAustralia
IndustryConstruction & Engineering
SizeMedium
Full Stock Analysis →
Clarity Pharmaceuticals
ASX:CU6
8
CountryAustralia
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Pyridam Farma
JKT:PYFA
3
CountrySingapore
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
SD Biosensor
KSC:137310
15
CountrySouth Korea
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
KTCS
KSC:058850
62
CountrySouth Korea
IndustryCommercial Services & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →